Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
17.17
0.26 (1.54%)
At close: Aug 14, 2025, 3:59 PM
17.17
0.00%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending June 30, 2025, Stoke Therapeutics generated $13.82M in revenue.
Revenue (ttm)
36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
285.59K
Employees
128
Market Cap
940.87M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.